BeOne Medicines (ONC) president disposes ADS to cover RSU tax
Rhea-AI Filing Summary
BeOne Medicines Ltd. President and COO Wu Xiaobin reported a small share disposal tied to tax withholding rather than a discretionary sale. On June 23, 2026, 1,292 American Depositary Shares (ADS) were sold at a weighted average price of $276.2592 per ADS under a mandatory tax withholding provision associated with the vesting of a restricted share unit award.
The restricted share units vest in four equal installments on each anniversary of June 22, 2022, subject to continued service, with potential accelerated vesting upon certain termination events. Following this transaction, Wu holds 12,365 ADS directly, 4,000 ADS indirectly through his spouse, and 1,273,724 ordinary shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,292 shares
Net Sell
4 txns
Insider
Wu Xiaobin
Role
President and COO
Sold
1,292 shs ($357K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American Depositary Shares | 1,292 | $276.2592 | $357K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 12,365 shares (Direct);
Ordinary Shares — 1,273,724 shares (Direct);
American Depositary Shares — 4,000 shares (Indirect, By Wife)
Footnotes (3)
- F1. Each American Depositary Share represents 13 Ordinary Shares.
- F2. The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Key Figures
ADS sold for tax withholding: 1,292 ADS
Weighted average sale price: $276.2592 per ADS
Direct ADS holdings after transaction: 12,365 ADS
+3 more
6 metrics
ADS sold for tax withholding
1,292 ADS
Open-market tax-related sale on June 23, 2026
Weighted average sale price
$276.2592 per ADS
Tax-withholding sale on June 23, 2026
Direct ADS holdings after transaction
12,365 ADS
Reported direct position following June 23, 2026 transactions
Indirect ADS holdings via spouse
4,000 ADS
Indirect ownership "By Wife" as of June 23, 2026
Direct ordinary share holdings
1,273,724 ordinary shares
Direct position as of June 23, 2026
ADS to ordinary share ratio
1 ADS = 13 ordinary shares
Equity structure referenced in footnote
Key Terms
American Depositary Shares, restricted share unit award, mandatory tax withholding, weighted average price, +1 more
5 terms
mandatory tax withholding financial
"pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement"
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
unvested securities financial
"Unvested securities are subject to accelerated vesting upon certain termination events."
FAQ
What insider transaction did BeOne Medicines (ONC) report for Wu Xiaobin?
BeOne Medicines reported that President and COO Wu Xiaobin disposed of 1,292 American Depositary Shares. The sale was executed to satisfy mandatory tax withholding obligations arising from the vesting of a restricted share unit award, rather than a discretionary open-market sale decision.
How many BeOne Medicines (ONC) ADS did Wu Xiaobin sell and at what price?
Wu Xiaobin disposed of 1,292 American Depositary Shares at a weighted average price of $276.2592 per ADS. The shares were sold in multiple trades between $276.23 and $276.475, executed specifically to cover tax withholding related to restricted share unit vesting.
Was the BeOne Medicines (ONC) insider sale by Wu Xiaobin discretionary?
The reported sale was not discretionary; it fulfilled a mandatory tax withholding provision. The transaction stemmed from the vesting of a previously granted restricted share unit award, meaning the disposition reflects tax obligations rather than a voluntary change in Wu Xiaobin’s investment stance.
What BeOne Medicines (ONC) holdings does Wu Xiaobin retain after the reported transaction?
After the transaction, Wu Xiaobin holds 12,365 American Depositary Shares directly, 4,000 ADS indirectly through his spouse, and 1,273,724 ordinary shares directly. These remaining positions indicate he continues to maintain a substantial equity stake in BeOne Medicines following the tax-related sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
